Review
Copyright ©2010 Baishideng Publishing Group Co.
World J Cardiol. Apr 26, 2010; 2(4): 78-88
Published online Apr 26, 2010. doi: 10.4330/wjc.v2.i4.78
Table 1 Outcomes of drug-eluting stents for unprotected left main coronary artery stenosis
Chieffo et al[4]Valgimigli et al[6]Park et al[5]de Lezo et al[28]Price et al[11]Kim et al[20]Meliga et al[29]Mehilli et al[48]
Stent typeSES, PESBMSSES, PESBMSSESBMSSESSESSES, PESSES, PESPESSES
DesignSingle center studySingle center studySingle center studySingle center studySingle center studySingle center studyMulticenter DELFT studyMulticenter randomized study
No. of patient85649586102121525063358302305
Age (yr)636664666058636967666969
Ejection fraction (%)51a574142606257NA50495354
Acute myocardial infarction (%)NANA1720a9.86.6NANA58.4NANA
Bifurcation involvement (%)81a58656671a43429454746363
Two-stent technique (%)74NA40a1541a18188917435149
Initial clinical outcomesIn-hospital30 dIn-hospitalIn-hospitalIn-hospitalIn-hospitalIn-hospital30 d
Death (%)0011700000312
Myocardial infarction (%)6849784810744
Stent thrombosis (%)0.00.00.00.00.00.00.04.00.0NA0.30.7
TVR (%)0.02.00.02.00.00.00.06.00.00.80.3 (TLR)0.7 (TLR)
Any events, %NANA15.019.07.08.04.010.010.011.05.04.6
Long-term outcomes (%)CumulativeCumulativeCumulativeCumulativeAfter dischargeCumulative3 yr2 yr
Mean follow-up (mo)661712121212911NANANA
Death (%)41414160001059109
Myocardial infarction (%)NANA4a12784211955
Stent thrombosis (%)0.10.0NANA0.00.00.00.00.20.60.30.7
TVR (%)19316a122a1723819149 (TLR)11 (TLR)
Any MACE (%)NANA24a458a26NA4429322121